XML 102 R84.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2024
Sep. 30, 2022
Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Supplier finance program, obligation $ 112   $ 94
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable   Accounts payable
Integration and Restructuring Expense      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Asset impairment charges $ 83    
Minimum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Maturity period of short-term investments at the time of purchase 3 months    
Supplier finance program, payment timing, period 90 days    
Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Maturity period of short-term investments at the time of purchase 1 year    
Supplier finance program, payment timing, period 150 days    
Life Sciences | Cost of products sold      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Asset impairment charges   $ 11  
Medical | Cost of products sold      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Asset impairment charges   54  
Medical | Integration, restructuring and transaction expense      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Asset impairment charges   $ 19